Literature DB >> 33230690

Cannabidiol Modulates Behavioural and Gene Expression Alterations Induced by Spontaneous Cocaine Withdrawal.

Ani Gasparyan1,2, Francisco Navarrete1,2, Marta Rodríguez-Arias2,3, José Miñarro2,3, Jorge Manzanares4,5.   

Abstract

The aim of this study was to evaluate the effects of cannabidiol (CBD) on the behavioural and gene expression changes in a new animal model of spontaneous cocaine withdrawal. For this purpose, male CD-1 mice were exposed to progressive increasing doses of cocaine for 12 days (15 to 60 mg/kg/day, i.p.), evaluating spontaneous cocaine withdrawal 6 h after the last cocaine administration. The effects of CBD (10, 20, and 40 mg/kg, i.p.) were evaluated on cocaine withdrawal-induced alterations in motor activity, somatic signs, and anxiety-like behaviour. Furthermore, gene expression changes in dopamine transporter (DAT) and tyrosine hydroxylase (TH) in the ventral tegmental area, and in cannabinoid receptors 1 (CNR1) and 2 (CNR2) in the nucleus accumbens, were analysed by real-time PCR. The results obtained in the study showed that mice exposed to the spontaneous cocaine withdrawal model presented increased motor activity, somatic withdrawal signs, and high anxiety-like behaviour. Interestingly, the administration of CBD normalized motor and somatic signs disturbances and induced an anxiolytic effect. Moreover, the administration of CBD blocked the increase of DAT and TH gene expression in mice exposed to the cocaine withdrawal, regulated the decrease of CNR1 and induced an additional upregulation of CNR2 gene expression. Thus, this model of spontaneous cocaine withdrawal induces clear behavioural and gene expression changes in mice. Interestingly, CBD alleviates these behavioural and gene expression alterations suggesting its potential for the management of cocaine withdrawal.

Entities:  

Keywords:  Cocaine; cannabidiol; mRNA; mice; withdrawal

Mesh:

Substances:

Year:  2020        PMID: 33230690      PMCID: PMC8116402          DOI: 10.1007/s13311-020-00976-6

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  53 in total

Review 1.  Treatment of cocaine cardiovascular toxicity: a systematic review.

Authors:  John R Richards; Dariush Garber; Erik G Laurin; Timothy E Albertson; Robert W Derlet; Ezra A Amsterdam; Kent R Olson; Edward A Ramoska; Richard A Lange
Journal:  Clin Toxicol (Phila)       Date:  2016-02-26       Impact factor: 4.467

2.  The effect of individual cocaine withdrawal symptoms on outcomes in cocaine users.

Authors:  Mehmet Sofuoglu; Susan Dudish-Poulsen; James Poling; Marc Mooney; Dorothy K Hatsukami
Journal:  Addict Behav       Date:  2004-11-02       Impact factor: 3.913

3.  Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment.

Authors:  K M Kampman; A I Alterman; J R Volpicelli; I Maany; E S Muller; D D Luce; E M Mulholland; A F Jawad; G A Parikh; F D Mulvaney; R M Weinrieb; C P O'Brien
Journal:  Psychol Addict Behav       Date:  2001-03

4.  Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence.

Authors:  Kyle M Kampman; Joseph R Volpicelli; Frank Mulvaney; Margaret Rukstalis; Arthur I Alterman; Helen Pettinati; Robert M Weinrieb; Charles P O'Brien
Journal:  Addict Behav       Date:  2002 Mar-Apr       Impact factor: 3.913

5.  Cocaine withdrawal symptoms predict medication response in cocaine users.

Authors:  Mehmet Sofuoglu; James Poling; Gerardo Gonzalez; Kishor Gonsai; Thomas Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2006       Impact factor: 3.829

6.  Cocaine abstinence symptomatology and treatment attrition.

Authors:  F D Mulvaney; A I Alterman; C R Boardman; K Kampman
Journal:  J Subst Abuse Treat       Date:  1999-03

7.  SPEECH MARKERS FOR CLINICAL ASSESSMENT OF COCAINE USERS.

Authors:  Carla Agurto; Raquel Norel; Mary Pietrowicz; Muhammad Parvaz; Sivan Kinreich; Keren Bachi; Guillermo Cecchi; Rita Z Goldstein
Journal:  Proc IEEE Int Conf Acoust Speech Signal Process       Date:  2019-04-17

Review 8.  Cocaine-related health emergencies in Europe: a review of sources of information, trends and implications for service development.

Authors:  Guillermo Mena; Isabelle Giraudon; Elena Álvarez; John M Corkery; João Matias; Kari Grasaasen; Noelia Llorens; Paul Griffiths; Julian Vicente
Journal:  Eur Addict Res       Date:  2012-10-05       Impact factor: 3.015

9.  Reliability and validity of the Cocaine Selective Severity Assessment.

Authors:  K M Kampman; J R Volpicelli; D E McGinnis; A I Alterman; R M Weinrieb; L D'Angelo; L E Epperson
Journal:  Addict Behav       Date:  1998 Jul-Aug       Impact factor: 3.913

Review 10.  Cocaine Use in Adolescents and Young Adults.

Authors:  Sheryl A Ryan
Journal:  Pediatr Clin North Am       Date:  2019-12       Impact factor: 3.278

View more
  5 in total

1.  Hippocampal Cannabinoid 1 Receptors Are Modulated Following Cocaine Self-administration in Male Rats.

Authors:  David De Sa Nogueira; Romain Bourdy; Rafael Alcala-Vida; Dominique Filliol; Virginie Andry; Yannick Goumon; Jean Zwiller; Pascal Romieu; Karine Merienne; Mary C Olmstead; Katia Befort
Journal:  Mol Neurobiol       Date:  2022-01-15       Impact factor: 5.590

Review 2.  Effects of Cannabidiol on Locomotor Activity.

Authors:  Fabrizio Calapai; Luigi Cardia; Gioacchino Calapai; Debora Di Mauro; Fabio Trimarchi; Ilaria Ammendolia; Carmen Mannucci
Journal:  Life (Basel)       Date:  2022-04-27

Review 3.  Cannabidiol and substance use disorder: Dream or reality.

Authors:  Saeideh Karimi-Haghighi; Yasaman Razavi; Daniela Iezzi; Andrew F Scheyer; Olivier Manzoni; Abbas Haghparast
Journal:  Neuropharmacology       Date:  2022-01-13       Impact factor: 5.273

Review 4.  Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders.

Authors:  Francisco Navarrete; María Salud García-Gutiérrez; Ani Gasparyan; Amaya Austrich-Olivares; Jorge Manzanares
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

5.  Antidepressant-like effects of cannabidiol in a rat model of early-life stress with or without adolescent cocaine exposure.

Authors:  Cristian Bis-Humbert; Rubén García-Cabrerizo; M Julia García-Fuster
Journal:  Pharmacol Rep       Date:  2021-06-02       Impact factor: 3.024

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.